Non-invasive ventilation support in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)
Authors:
P. Matuška; O. Pilařová; Z. Merta; J. Skřičková
Authors‘ workplace:
Klinika nemocí plicních a TBC Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednostka doc. MUDr. Jana Skřičková, CSc.
Published in:
Vnitř Lék 2006; 52(3): 241-248
Category:
Original Contributions
Overview
Aim:
To verify that the use of noninvasive ventilatory support in acute exacerbation of chronic obstructive pulmonary disease leads to decreasing the number of deaths, shortening in-hospital stay and decreasing number of endotracheal intubations (ETI).
Setting:
The study was conducted at a respiratory department’s ICU in 2002 - 2004.
Methods:
Patients hospitalized on ICU with acute exacerbation of COPD, respiratory acidosis and global respiratory failure were randomised into two groups. Patients in group A were treated by conservative medical therapy (oxygen, bronchodilator, corticosteroid), patients in group B received noninvasive ventilation with face mask. The parameters followed were: decrease in the number of deaths, shortening of ICU stay, reduction of ETI, faster improvement of breathing frequency, heart rate, pH, PaO2, paCO2, lactate, dyspnoea symptom score and lung functions.
Results:
Each group consisted of 30 randomised patients. There were 10 intubated patients in group A, as opposed to 3 in group B (N = 60; P = 0.034). Average length of ICU stay was 9.8 days in group A and 7.1 days in group B (N = 60; P = 0.756). Mortality rate was identical in both groups: 3 patients survived, 7 patients died. We found faster decrease of breathing frequency after one hour of noninvasive ventilation in group B (28.3 ± 7.1 vs. 24.6 ± 6.3, N = 59, p = 0.03).
Conclusion:
No difference was found in mortality rate. We observed decreasing of ETI rate with NIV. We found a tendency to shortening of ICU stay. There was faster improvement of breathing frequency after one hour of NIV.
Key words:
noninvasive ventilation - chronic obstructive pulmonary disease - respiratory failure
Sources
1. Simonds AK. Non-invasive Respiratory Support. Second edition, London: Arnold, 2001, 58-60.
2. Matuska P, Pilarova O, Merta Z et al. The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD). European Respiratory Society Annual Congress 2002, Stockholm, poster.
3. Světová iniciativa o chronické obstrukční plicní nemoci. Praha: Vltavín 2000, 13.
4. Dostál J et al. Základy umělé plicní ventilace. 2. ed. Praha: Maxdorf 2005: 180-181.
5. Musil J et al. Léčba chronické obstrukční plicním nemoci. Praha: Grada Publishing 1999, 55.
6. Hill NS, Levy MM. Ventilator management strategies for critical care. New York, Basel: Marcel Dekker, Inc. 2001.
7. Girou E, Schortgen F, Delclaux C et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA 2000; 284: 2361-2367.
8. Lightowler JV, Wedzicha JA, Elliot MW et al. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 2003; 326: 185-189.
9. Peter JV, Moran JL, Philips-Hughes H et al. Noninvasive ventilation in acute respiratory failure - a meta-analysis update. Crit Care Med 2002; 30: 555-562.
10. Hilbert G, Geruson D, Gbikpi-Benissan G et al. Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPD. Intensive Care Med 1997; 23: 955-961.
11. Knaus VA et al. APACHE II. A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
12. Brochard L, Isabey D, Piquet J et al. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Eng J Med 1990; 323: 1523-1530.
13. Bott J, Carrol MP, Conway JH et al. Randomised controlled trial of nasal ventilation in acute respiratory failure in chronic obstructive pulmonary disease. Lancet 1993; 341: 1555-1557.
14. Kramer N, Meyer TJ, Meharg J et al. Randomised, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151: 1799-1806.
15. Brochard L, Mancebo J, Wysocki M et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 817-822.
16. Barbe F, Togores B, Rubi M et al. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. Thorax 1996; 9: 1240-1245.
17. Wood KA, Lewis L, Von Harz B et al. The use Noninvasive positive pressure ventilation in Emergency Department. Chest 1998; 113: 1339-1346.
18. Celikel T, Sungur M, Ceyhan B et al. Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic respiratory failure. Chest 1998; 114: 1636-1642.
19. Confalonieri M, Gorini M, Ambrosino N et al. Respiratory intensive care units in Italy: a national consensus and prospective cohort study. Thorax 2001; 56: 373-378.
20. Bardi G, Pierotello R, Desideri M et al. Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled study. Eur Respir J 2000; 15: 98-104.
21. Angus RM, Ahmed AA, Fenwick LJ. Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease. Thorax 1996; 51: 1048-1050.
22. Plant PK, Owen JL, Elliot MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355: 1931-1935.
23. Conti G, Antonelli M, Navalesi P et al. Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomised trial. Intensive Care Med 2002; 28: 1701-1707.
24. Evans TW. International Consensus Conferences in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failure. Organised jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care medicine, and the Societe de Reanimation de Langue Francoise, and approved by the ATS Board of Directors, December 2000. Intensive Care Med 2001; 27: 166-178.
25. Moretti M, Cilione C, Tampieri A et al. Incidence and cause of non-invasive mechanical ventilation failure after initial success. Thorax 2000; 55: 550-554.
26. Lightowler JV, Elliot MW. Predicting the outcome from NIV for acute exacerbations of COPD. Thorax 2000; 55: 815-816.
27. Elliot MW, Confalonieri M, Nava S. Where to perform noninvasive ventilation? Eur Respir J 2002; 19: 1159-1166.
28. Carlucci A, Delmastro M, Rubini F et al. Changes in the practice of noninvasive ventilation in treating COPD patients over 8 years. Intensive Care Med 2003; 29: 419-425.
29. Paus-Jenssen ES, Reid JK, Cockcroft DW et al. The use of noninvasive ventilation in acute respiratory failure at a tertiary care center. Chest 2004; 126: 165-172.
30. Keenan SP, Gregor J, Sibbad WJ et al. Noninvasive positive pressure ventilation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: More effective and less expensive. Crit Care Med 2000; 28: 2094-2102.
31. Plant PK, Owen JL, Parrott S et al. Cost effectivness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial. BMJ 2003; 326: 956.
32. Majid A, Hill NS. Noninvasive ventilation for acute respiratory failure. Current Opinion In Critical Care 2005, 11: 77-81.
33. Plant PK, Owen JL, Elliot MW. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome. Thorax 2001; 56: 708-712.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2006 Issue 3
Most read in this issue
- Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis
- Extension of QT interval as a consequence of risk factor accumulation – case study
- Immunoglobulin A and renal diseases
- Non-invasive ventilation support in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)